Pure Global

Communication Training in Promoting Employment Retention Among Cancer Patients - Trial NCT02895490

Access comprehensive clinical trial information for NCT02895490 through Pure Global AI's free database. This phase not specified trial is sponsored by Virginia Commonwealth University and is currently Terminated. The study focuses on Unspecified Adult Solid Tumor, Protocol Specific. Target enrollment is 8 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT02895490
Terminated
other
Trial Details
ClinicalTrials.gov โ€ข NCT02895490
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Communication Training in Promoting Employment Retention Among Cancer Patients
Using Communication Training to Promote Employment Retention Among Cancer Survivors

Study Focus

educational intervention

Interventional

other

Sponsor & Location

Virginia Commonwealth University

Richmond, United States of America

Timeline & Enrollment

N/A

Jan 01, 2014

Oct 01, 2015

8 participants

Primary Outcome

Changes in perceived self-efficacy pre-intervention and post-intervention.,Compare requested pre-intervention measures to received post-intervention measures.,Compare longitudinal changes in knowledge scale before and after combination information and communication skills training.

Summary

This randomized clinical trial studies communication training in promoting employment
 retention among cancer patients. Communication training may improve patient-employer
 communication and increase the likelihood that cancer patients will remain employed, reduce
 patients' time away from work, and increase workplace accommodations that enable patients to
 balance treatment and work.

ICD-10 Classifications

Carcinoma in situ, unspecified
Malignant neoplasm, without specification of site
Malignant neoplasm, primary site unspecified
Carcinoma in situ of other and unspecified genital organs
Malignant neoplasm: Connective and soft tissue, unspecified

Data Source

ClinicalTrials.gov

NCT02895490

Non-Device Trial